Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$1.01 - $1.81 $5,050 - $9,050
-5,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.66 - $2.4 $8,300 - $12,000
5,000 New
5,000 $11,000
Q2 2019

Aug 14, 2019

SELL
$2.1 - $3.93 $10,500 - $19,650
-5,000 Closed
0 $0
Q4 2018

May 23, 2019

BUY
$2.13 - $4.8 $10,650 - $24,000
5,000 New
5,000 $12,000

About ACELRX PHARMACEUTICALS INC


  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.